<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font25 { font-size : 25; } .font29 { font-size : 29; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">HIV </span>
   <span class="font29">TDR </span>
   <span class="font25">HIV- </span>
   <span class="font22">[]. </span>
   <span class="font20">Drug </span>
   <span class="font20">Resistance </span>
   <span class="font20">persons </span>
   <span class="font19">;():–. </span>
   <span class="font17">resistance </span>
   <span class="font16">drug </span>
   <span class="font16">Kenya </span>
   <span class="font16">Pathogens </span>
   <span class="font15">Biology </span>
   <span class="font15">{border-style </span>
   <span class="font14">Antiretroviral </span>
   <span class="font14">prevalence </span>
   <span class="font14">Sciences </span>
   <span class="font14">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">Transmitted </span>
   <span class="font14">observed </span>
   <span class="font14">AIDS </span>
   <span class="font13">ARV </span>
   <span class="font13">Viral </span>
   <span class="font13">test </span>
   <span class="font13">East </span>
   <span class="font13">Life </span>
   <span class="font13">years </span>
   <span class="font13">(.%) </span>
   <span class="font13">Africa </span>
   <span class="font13">Viruses </span>
   <span class="font13">study </span>
   <span class="font12">HIV-infected </span>
   <span class="font12">Hum </span>
   <span class="font12">Medicine </span>
   <span class="font12">Ndhiwa </span>
   <span class="font12">Res </span>
   <span class="font12">Retroviruses. </span>
   <span class="font12">Type </span>
   <span class="font12">aged </span>
   <span class="font12">treatment </span>
   <span class="font12">using </span>
   <span class="font12">viral </span>
   <span class="font12">.–.) </span>
   <span class="font12">Immunodeficiency </span>
   <span class="font12">Microbiology </span>
   <span class="font12">Uganda </span>
   <span class="font12">associated </span>
   <span class="font12">high </span>
   <span class="font12">studies </span>
   <span class="font12">subtype </span>
   <span class="font12">used </span>
   <span class="font12">(IQR </span>
   <span class="font12">CZ. </span>
   <span class="font12">HIV: </span>
   <span class="font12">Microbial </span>
   <span class="font12">Persons </span>
   <span class="font12">Prevention </span>
   <span class="font12">antibody </span>
   <span class="font12">cell </span>
   <span class="font12">included </span>
   <span class="font12">infected </span>
   <span class="font12">mutations </span>
   <span class="font12">recency </span>
   <span class="font12">use </span>
   <span class="font12">AHI/RHI </span>
   <span class="font12">ART </span>
   <span class="font12">Analysis </span>
   <span class="font12">Dis. </span>
   <span class="font12">Health </span>
   <span class="font12">Infect </span>
   <span class="font12">Molecular </span>
   <span class="font12">Organisms </span>
   <span class="font12">Retroviruses </span>
   <span class="font12">[,]. </span>
   <span class="font12">count </span>
   <span class="font12">data </span>
   <span class="font12">higher </span>
   <span class="font12">incidence </span>
   <span class="font12">level </span>
   <span class="font12">px; </span>
   <span class="font12">regions </span>
   <span class="font12">rural </span>
   <span class="font12">testing </span>
   <span class="font12">{font-family </span>
   <span class="font11">(/) </span>
   <span class="font11">HIVdb </span>
   <span class="font11">Individuals </span>
   <span class="font11">Mombasa </span>
   <span class="font11">RNA </span>
   <span class="font11">Stanford </span>
   <span class="font11">Surveillance </span>
   <span class="font11">TDRMs </span>
   <span class="font11">Treatment </span>
   <span class="font11">[], </span>
   <span class="font11">distribution </span>
   <span class="font11">eligible </span>
   <span class="font11">font-size </span>
   <span class="font11">infection </span>
   <span class="font11">load </span>
   <span class="font11">low </span>
   <span class="font11">moderate </span>
   <span class="font11">positive </span>
   <span class="font11">reported </span>
   <span class="font11">sequences </span>
   <span class="font11">sub-Saharan </span>
   <span class="font11">transmission </span>
   <span class="font11">transmitted </span>
   <span class="font11">western </span>
   <span class="font11">;():e./journal.pone. </span>
   <span class="font11">AHI </span>
   <span class="font11">Africa. </span>
   <span class="font11">Control </span>
   <span class="font11">Entebbe </span>
   <span class="font11">Global </span>
   <span class="font11">HamersRL, </span>
   <span class="font11">Infected </span>
   <span class="font11">Inhibitors; </span>
   <span class="font11">Medical </span>
   <span class="font11">One. </span>
   <span class="font11">al.Transmitted </span>
   <span class="font11">analyses </span>
   <span class="font11">assessed </span>
   <span class="font11">compared </span>
   <span class="font11">date </span>
   <span class="font11">double; </span>
   <span class="font11">drug-naïve </span>
   <span class="font11">mutation </span>
   <span class="font11">reverse </span>
   <span class="font11">survey </span>
   <span class="font11">tree </span>
   <span class="font11">.%) </span>
   <span class="font11">./AID.. </span>
   <span class="font11">./S-()- </span>
   <span class="font11">AIDS. </span>
   <span class="font11">Centers </span>
   <span class="font11">Clin </span>
   <span class="font11">Disease </span>
   <span class="font11">EFVd, </span>
   <span class="font11">Impact </span>
   <span class="font11">Infection </span>
   <span class="font11">Information </span>
   <span class="font11">Kenya, </span>
   <span class="font11">Laboratory </span>
   <span class="font11">LyagobaF, </span>
   <span class="font11">Mutations </span>
   <span class="font11">NRTI </span>
   <span class="font11">NVPd </span>
   <span class="font11">National </span>
   <span class="font11">Newly </span>
   <span class="font11">Patients </span>
   <span class="font11">Phylogenetic </span>
   <span class="font11">Population </span>
   <span class="font11">Prevalence </span>
   <span class="font11">Research </span>
   <span class="font11">Reverse </span>
   <span class="font11">Ther. </span>
   <span class="font11">Transcriptase </span>
   <span class="font11">age </span>
   <span class="font11">antiretroviral </span>
   <span class="font11">assays </span>
   <span class="font11">based </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">characteristics </span>
   <span class="font11">first-line </span>
   <span class="font11">gene </span>
   <span class="font11">health </span>
   <span class="font11">infections </span>
   <span class="font11">information </span>
   <span class="font11">levels </span>
   <span class="font11">log </span>
   <span class="font11">monitoring </span>
   <span class="font11">net </span>
   <span class="font11">overall </span>
   <span class="font11">phylogenetic </span>
   <span class="font11">pol </span>
   <span class="font11">previous </span>
   <span class="font11">recent </span>
   <span class="font11">recently </span>
   <span class="font11">region </span>
   <span class="font11">sequence </span>
   <span class="font11">serological </span>
   <span class="font11">settings </span>
   <span class="font11">solid; </span>
   <span class="font11">study. </span>
   <span class="font11">surveys </span>
   <span class="font11">women </span>
   <span class="font11">written </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(%) </span>
   <span class="font11">(.%), </span>
   <span class="font11">(mutation </span>
   <span class="font11">.%), </span>
   <span class="font11">.), </span>
   <span class="font11">.–.). </span>
   <span class="font11">Antiretroviral-Naïve </span>
   <span class="font11">Antivir </span>
   <span class="font11">Data </span>
   <span class="font11">Fig </span>
   <span class="font11">Frontières </span>
   <span class="font11">Kampala </span>
   <span class="font11">Kenya. </span>
   <span class="font11">Lentivirus </span>
   <span class="font11">Lentivirus: </span>
   <span class="font11">Médecins </span>
   <span class="font11">NNRTI </span>
   <span class="font11">Pathology </span>
   <span class="font11">Recent </span>
   <span class="font11">Resource-Limited </span>
   <span class="font11">Sans </span>
   <span class="font11">Study. </span>
   <span class="font11">Therapy </span>
   <span class="font11">Uganda. </span>
   <span class="font11">Viruses: </span>
   <span class="font11">Women </span>
   <span class="font11">acutely </span>
   <span class="font11">baseline </span>
   <span class="font11">bold </span>
   <span class="font11">courier; </span>
   <span class="font11">drugs </span>
   <span class="font11">duration </span>
   <span class="font11">em; </span>
   <span class="font11">evolutionary </span>
   <span class="font11">excluded </span>
   <span class="font11">genotyping </span>
   <span class="font11">high-level </span>
   <span class="font11">history </span>
   <span class="font11">identified </span>
   <span class="font11">laboratory </span>
   <span class="font11">likely </span>
   <span class="font11">low-level </span>
   <span class="font11">majority </span>
   <span class="font11">method </span>
   <span class="font11">negative </span>
   <span class="font11">population-based </span>
   <span class="font11">potential </span>
   <span class="font11">pt;} </span>
   <span class="font11">public </span>
   <span class="font11">rapid </span>
   <span class="font11">reference </span>
   <span class="font11">resistance. </span>
   <span class="font11">responses </span>
   <span class="font11">results </span>
   <span class="font11">risk </span>
   <span class="font11">score </span>
   <span class="font11">selected </span>
   <span class="font11">seroconversion </span>
   <span class="font11">shown </span>
   <span class="font11">subtypes </span>
   <span class="font11">subtyping </span>
   <span class="font11">therapy </span>
   <span class="font11">transcriptase </span>
  </p>
 </body>
</html>
